Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Barry Massie, MD

    TitleProfessor in Residence
    SchoolUCSF School of Medicine
    DepartmentMedicine
    AddressVAMC 203
    Phone415-750-2112

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the heart failure society of america and american college of clinical pharmacy cardiology practice and research network. Pharmacotherapy. 2013 May; 33(5):529-48.
        View in: PubMed
      2. van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol. 2013 May 14; 61(19):1973-81.
        View in: PubMed
      3. Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie BM, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail. 2013 Apr; 15(4):456-64.
        View in: PubMed
      4. Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2012 Sep 1; 5(5):571-8.
        View in: PubMed
      5. Sung RK, Massie BM, Varosy PD, Moore H, Rumsfeld J, Lee BK, Keung E. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm. 2012 Dec; 9(12):1954-61.
        View in: PubMed
      6. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail. 2012 Nov; 14(11):1257-64.
        View in: PubMed
      7. Costanzo MR, Heywood JT, Massie BM, Iwashita J, Henderson L, Mamatsashvili M, Sisakian H, Hayrapetyan H, Sager P, van Veldhuisen DJ, Albrecht D. A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease. Eur J Heart Fail. 2012 Aug; 14(8):922-30.
        View in: PubMed
      8. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012 May 17; 366(20):1859-69.
        View in: PubMed
      9. O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie BM. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur J Heart Fail. 2012 Jun; 14(6):605-12.
        View in: PubMed
      10. McMurray JJ, Abraham WT, Dickstein K, Køber L, Massie BM, Krum H. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail. 2012 Apr; 14(4):341-3.
        View in: PubMed
      11. Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, Miller AB, Piña IL, Thomson S, Varosy PD, Zile MR, Cleland JG, Givertz MM, Metra M, Ponikowski P, Voors AA, Davison BA, Cotter G, Wolko D, Delucca P, Salerno CM, Mansoor GA, Dittrich H, O'Connor CM, Massie BM. The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug Saf. 2012 Mar 1; 35(3):233-44.
        View in: PubMed
      12. Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, Piano MR, Ross HJ, Sabbah HN, Starling RC, Udelson JE, Yancy CW, Zile MR, Massie BM. The Heart Failure Society of America in 2020: a vision for the future. J Card Fail. 2012 Feb; 18(2):90-3.
        View in: PubMed
      13. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, Komajda M, Kuskowski M, Massie BM. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial. Circ Heart Fail. 2012 Mar 1; 5(2):217-25.
        View in: PubMed
      14. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011 Dec 6; 124(23):2491-501.
        View in: PubMed
      15. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8.
        View in: PubMed
      16. O'Connor CM, Fiuzat M, Lombardi C, Fujita K, Jia G, Davison BA, Cleland J, Bloomfield D, Dittrich HC, Delucca P, Givertz MM, Mansoor G, Ponikowski P, Teerlink JR, Voors AA, Massie BM, Cotter G, Metra M. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ Heart Fail. 2011 Nov; 4(6):724-32.
        View in: PubMed
      17. Massie BM. Globalization of clinical trials how should we interpret differences in outcomes? J Am Coll Cardiol. 2011 Aug 23; 58(9):923-4.
        View in: PubMed
      18. Krum H, Elsik M, Schneider HG, Ptaszynska A, Black M, Carson PE, Komajda M, Massie BM, McKelvie RS, McMurray JJ, Zile MR, Anand IS. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail. 2011 Sep; 4(5):561-8.
        View in: PubMed
      19. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 7; 365(1):32-43.
        View in: PubMed
      20. Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie BM, Carson PE. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail. 2011 Sep; 4(5):569-77.
        View in: PubMed
      21. Steinman MA, Harlow JB, Massie BM, Kaboli PJ, Fung KZ, Heidenreich PA. Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans. J Gen Intern Med. 2011 Oct; 26(10):1152-9.
        View in: PubMed
      22. Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol. 2011 May 10; 57(19):1899-907.
        View in: PubMed
      23. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation. J Card Fail. 2011 May; 17(5):349-58.
        View in: PubMed
      24. Massie BM. Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist. J Mol Cell Cardiol. 2011 Oct; 51(4):438-40.
        View in: PubMed
      25. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. Circ Heart Fail. 2011 May; 4(3):378-87.
        View in: PubMed
      26. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie BM, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. J Am Coll Cardiol. 2011 May 17; 57(20):2115-24.
        View in: PubMed
      27. Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J. 2011 Jun; 32(12):1519-34.
        View in: PubMed
      28. Ghali JK, Massie BM, Mann DL, Rich MW. Guidelines are merely guidelines. J Card Fail. 2011 Mar; 17(3):208-9.
        View in: PubMed
      29. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011 May; 4(3):324-31.
        View in: PubMed
      30. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011 Jan; 13(1):107-14.
        View in: PubMed
      31. Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2011 Jan; 17(1):90.e1-4.
        View in: PubMed
      32. Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol. 2010 Dec 14; 56(25):2077-80.
        View in: PubMed
      33. Ghali JK, Massie BM, Mann DL, Rich MW. Guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2010 Dec; 16(12):915-8.
        View in: PubMed
      34. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail. 2011 Jan; 4(1):27-35.
        View in: PubMed
      35. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010 Oct 7; 363(15):1419-28.
        View in: PubMed
      36. Ponikowski P, Mitrovic V, O'Connor CM, Dittrich H, Cotter G, Massie BM, Givertz MM, Chen E, Murray M, Weatherley BD, Fujita KP, Metra M. Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function. Eur J Heart Fail. 2010 Nov; 12(11):1238-46.
        View in: PubMed
      37. Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie BM, O'Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010 Jul 27; 56(5):343-51.
        View in: PubMed
      38. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B. Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. J Am Coll Cardiol. 2010 Jul 27; 56(5):362-8.
        View in: PubMed
      39. Massie BM. Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear! Eur J Heart Fail. 2010 Jul; 12(7):639-41.
        View in: PubMed
      40. Gottlieb SS, Givertz MM, Metra M, Gergich K, Bird S, Jones-Burton C, Massie B, Cotter G, Ponikowski P, Weatherley B, O'Connor C, Dittrich H. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. J Card Fail. 2010 Sep; 16(9):714-9.
        View in: PubMed
      41. McCullough PA, Haapio M, Mankad S, Zamperetti N, Massie B, Bellomo R, Berl T, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bobek I, Cruz DN, Daliento L, Davenport A, Hillege H, House AA, Katz N, Maisel A, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zanco P, Ronco C, Berl T. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010 Jun; 25(6):1777-84.
        View in: PubMed
      42. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010 Mar 30; 121(12):1393-405.
        View in: PubMed
      43. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail. 2010 May; 12(5):499-507.
        View in: PubMed
      44. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25.
        View in: PubMed
      45. Massie BM. The Journal of Cardiac Failure: passing the baton. J Card Fail. 2010 Jan; 16(1):1.
        View in: PubMed
      46. Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. J Card Fail. 2010 Jan; 16(1):25-35.
        View in: PubMed
      47. Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009 Nov 24; 54(22):2023-31.
        View in: PubMed
      48. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie BM. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail. 2010 Feb; 16(2):128-34.
        View in: PubMed
      49. Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O'Connor CM. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology. 2010; 115(1):29-36.
        View in: PubMed
      50. Massie BM. Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspective. J Clin Hypertens (Greenwich). 2009 Sep; 11(9):462-5.
        View in: PubMed
      51. Patterson ME, Grant WC, Glickman SW, Massie BM, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Teo KK, Schulman KA, Reed SD. Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. J Card Fail. 2009 Dec; 15(10):819-27.
        View in: PubMed
      52. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70.
        View in: PubMed
      53. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009 Mar 31; 119(12):1616-24.
        View in: PubMed
      54. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 3; 119(4):606-18.
        View in: PubMed
      55. Metra M, Dei Cas L, Massie BM. Treatment of heart failure in the elderly: never say it's too late. Eur Heart J. 2009 Feb; 30(4):391-3.
        View in: PubMed
      56. Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):271-7.
        View in: PubMed
      57. Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):219-28.
        View in: PubMed
      58. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008 Dec 4; 359(23):2456-67.
        View in: PubMed
      59. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008 Nov 25; 118(22):2259-67.
        View in: PubMed
      60. Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail. 2008 Oct; 14(8):631-40.
        View in: PubMed
      61. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Circ Heart Fail. 2008 May; 1(1):9-16.
        View in: PubMed
      62. Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF, Califf RM, Gheorghiade M. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008 May; 1(1):25-33.
        View in: PubMed
      63. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24.
        View in: PubMed
      64. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008 Feb; 10(2):188-95.
        View in: PubMed
      65. McMurray JJ, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie BM. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008 Feb; 10(2):149-56.
        View in: PubMed
      66. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation. 2008 Jan 29; 117(4):526-35.
        View in: PubMed
      67. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007 Oct 16; 50(16):1551-60.
        View in: PubMed
      68. Chatterjee K, Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail. 2007 Sep; 13(7):569-76.
        View in: PubMed
      69. Massie BM. Review: Available evidence does not support the use of beta blockers as first line treatment for hypertension. Evid Based Med. 2007 Aug; 12(4):112.
        View in: PubMed
      70. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6.
        View in: PubMed
      71. Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA. Beta-blocker dosing in community-based treatment of heart failure. Am Heart J. 2007 Jun; 153(6):1029-36.
        View in: PubMed
      72. Heidenreich PA, Gholami P, Sahay A, Massie B, Goldstein MK. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial. Circulation. 2007 Jun 5; 115(22):2829-34.
        View in: PubMed
      73. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design. Am Heart J. 2007 Apr; 153(4):478-84.
        View in: PubMed
      74. Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Am J Cardiol. 2007 May 1; 99(9):1263-8.
        View in: PubMed
      75. Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press. 2007; 16(1):13-9.
        View in: PubMed
      76. Abraham WT, Massie BM, Lukas MA, Lottes SR, Nelson JJ, Fowler MB, Greenberg B, Gilbert EM, Franciosa JA. Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. Congest Heart Fail. 2007 Jan-Feb; 13(1):16-21.
        View in: PubMed
      77. Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Am Heart J. 2007 Jan; 153(1):42-53.
        View in: PubMed
      78. Marcus GM, Cohen J, Varosy PD, Vessey J, Rose E, Massie BM, Chatterjee K, Waters D. The utility of gestures in patients with chest discomfort. Am J Med. 2007 Jan; 120(1):83-9.
        View in: PubMed
      79. Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Fowler MB, Greenberg B, Gilbert EM, Abraham WT. Heart failure in community practice: relationship to age and sex in a beta-blocker registry. Congest Heart Fail. 2006 Nov-Dec; 12(6):317-23.
        View in: PubMed
      80. Greenberg B, Lottes SR, Nelson JJ, Lukas MA, Fowler MB, Massie BM, Abraham WT, Gilbert EM, Franciosa JA. Predictors of clinical outcomes in patients given carvedilol for heart failure. Am J Cardiol. 2006 Dec 1; 98(11):1480-4.
        View in: PubMed
      81. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
        View in: PubMed
      82. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 6; 47(11):2245-52.
        View in: PubMed
      83. Quiñones MA, Zile MR, Massie BM, Kass DA. Chronic heart failure: a report from the Dartmouth Diastole Discourses. Congest Heart Fail. 2006 May-Jun; 12(3):162-5.
        View in: PubMed
      84. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006 Aug; 27(16):1908-20.
        View in: PubMed
      85. Massie BM, Force T. The year in heart failure 2005. J Card Fail. 2006 Feb; 12(1):1-9.
        View in: PubMed
      86. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005 Dec 20; 112(25):3958-68.
        View in: PubMed
      87. Carson P, Massie BM, McKelvie R, McMurray J, Komajda M, Zile M, Ptaszynska A, Frangin G. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005 Oct; 11(8):576-85.
        View in: PubMed
      88. Massie BM. Aspirin use in chronic heart failure: what should we recommend to the practitioner? J Am Coll Cardiol. 2005 Sep 20; 46(6):963-6.
        View in: PubMed
      89. Freudenberger RS, Massie BM. Silent cerebral infarction in heart failure: vascular or thromboembolic? J Card Fail. 2005 Sep; 11(7):490-1.
        View in: PubMed
      90. Massie BM, Fabi MR. Clinical trials in diastolic heart failure. Prog Cardiovasc Dis. 2005 May-Jun; 47(6):389-95.
        View in: PubMed
      91. Massie BM. Heart failure trials: are they becoming impractical? J Card Fail. 2005 Apr; 11(3):161-3.
        View in: PubMed
      92. Teerlink JR, Massie BM. Nesiritide and worsening of renal function: the emperor's new clothes? Circulation. 2005 Mar 29; 111(12):1459-61.
        View in: PubMed
      93. Massie BM. Isosorbide dinitrate plus hydralazine was effective for advanced heart failure in black patients. ACP J Club. 2005 Mar-Apr; 142(2):37.
        View in: PubMed
      94. Massie BM. The year in heart failure: 2004. J Card Fail. 2005 Feb; 11(1):1-6.
        View in: PubMed
      95. Packer M, McMurray J, Massie BM, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005 Feb; 11(1):12-20.
        View in: PubMed
      96. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF, Gheorghiade M, O'Connor CM. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004 Dec; 10(6):460-6.
        View in: PubMed
      97. Massie BM. Should the management of heart failure become a new subspecialty? J Card Fail. 2004 Oct; 10(5):363-5.
        View in: PubMed
      98. Franciosa JA, Massie BM, Lukas MA, Nelson JJ, Lottes S, Abraham WT, Fowler M, Gilbert EM, Greenberg B. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. Am Heart J. 2004 Oct; 148(4):718-26.
        View in: PubMed
      99. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation. 2004 Sep 21; 110(12):1514-7.
        View in: PubMed
      100. Hlatky MA, Massie BM. Cardiac resynchronization for heart failure. Ann Intern Med. 2004 Sep 7; 141(5):399-400.
        View in: PubMed
      101. Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol. 2004 Aug; 15(8):2195-203.
        View in: PubMed
      102. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med. 2004 Apr 15; 116(8):509-16.
        View in: PubMed
      103. Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004 Apr; 10(2):101-12.
        View in: PubMed
      104. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004 Feb; 147(2):331-8.
        View in: PubMed
      105. Massie BM. 2003: The year in heart failure. J Card Fail. 2004 Feb; 10(1):1-3.
        View in: PubMed
      106. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004 Jan 7; 43(1):61-7.
        View in: PubMed
      107. Ansari M, Araoz PA, Gerard SK, Watzinger N, Lund GK, Massie BM, Higgins CB, Saloner DA. Comparison of late enhancement cardiovascular magnetic resonance and thallium SPECT in patients with coronary disease and left ventricular dysfunction. J Cardiovasc Magn Reson. 2004; 6(2):549-56.
        View in: PubMed
      108. DeMets DL, Fleming TR, Rockhold F, Massie B, Merchant T, Meisel A, Mishkin B, Wittes J, Stump D, Califf R. Liability issues for data monitoring committee members. Clin Trials. 2004; 1(6):525-31.
        View in: PubMed
      109. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003 Dec 16; 108(24):2987-92.
        View in: PubMed
      110. Massie BM. A comment on COMET: how to interpret a positive trial? J Card Fail. 2003 Dec; 9(6):425-8.
        View in: PubMed
      111. Massie BM. The dilemma of drug development for heart failure: when is the time to initiate large clinical trials? J Card Fail. 2003 Oct; 9(5):347-9.
        View in: PubMed
      112. Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63.
        View in: PubMed
      113. Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail. 2003 Aug; 9(4):266-77.
        View in: PubMed
      114. Havranek EP, Krumholz HM, Dudley RA, Adams K, Gregory D, Lampert S, Lindenfeld J, Massie BM, Pina I, Restaino S, Rich MW, Konstam MA. Aligning quality and payment for heart failure care: defining the challenges. J Card Fail. 2003 Aug; 9(4):251-4.
        View in: PubMed
      115. Ansari M, Alexander M, Tutar A, Massie BM. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J. 2003 Jul; 146(1):115-20.
        View in: PubMed
      116. Ansari M, Massie BM. Heart failure: how big is the problem? Who are the patients? What does the future hold? Am Heart J. 2003 Jul; 146(1):1-4.
        View in: PubMed
      117. Massie BM. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and bad. J Am Coll Cardiol. 2003 Jun 4; 41(11):2018-21.
        View in: PubMed
      118. Teerlink JR, Massie BM. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION. J Card Fail. 2003 Jun; 9(3):158-63.
        View in: PubMed
      119. Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, Massie BM. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 2003 Jun 10; 107(22):2799-804.
        View in: PubMed
      120. Massie BM. Negative, neutral, and discordant results: what should an editor do? J Card Fail. 2003 Apr; 9(2):77-9.
        View in: PubMed
      121. Massie BM, Ansari MN. Specialty care for heart failure: does it improve outcomes? Am Heart J. 2003 Feb; 145(2):209-13.
        View in: PubMed
      122. Shlipak MG, Chertow GC, Massie BM. Beware the rising creatinine level. J Card Fail. 2003 Feb; 9(1):26-8.
        View in: PubMed
      123. Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003 Feb; 145(2 Suppl):S3-17.
        View in: PubMed
      124. Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Rydén L. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003 Jan; 89(1):42-8.
        View in: PubMed
      125. Ansari M, Alexander M, Tutar A, Bello D, Massie BM. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 2003 Jan 1; 41(1):62-8.
        View in: PubMed
      126. Massie BM. What is the significance of a journal's impact factor? J Card Fail. 2002 Dec; 8(6):363-4.
        View in: PubMed
      127. Massie BM. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians. J Card Fail. 2002 Aug; 8(4):197-201.
        View in: PubMed
      128. Massie BM. Obesity and heart failure--risk factor or mechanism? N Engl J Med. 2002 Aug 1; 347(5):358-9.
        View in: PubMed
      129. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 Jun; 8(3):136-41.
        View in: PubMed
      130. Massie BM. Treating heart failure: it's time for new paradigms and novel approaches. J Card Fail. 2002 Jun; 8(3):117-9.
        View in: PubMed
      131. Massie BM. Comment--LVADs as long-term cardiac replacement: Success but on what terms and at what cost? J Card Fail. 2002 Apr; 8(2):61-2.
        View in: PubMed
      132. Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002 Mar 27; 287(12):1541-7.
        View in: PubMed
      133. Massie BM. Neurohormonal blockade in chronic heart failure. How much is enough? Can there be too much?. J Am Coll Cardiol. 2002 Jan 2; 39(1):79-82.
        View in: PubMed
      134. Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J. 2001 Sep; 22(17):1601-12.
        View in: PubMed
      135. Dauterman KW, Go AS, Rowell R, Gebretsadik T, Gettner S, Massie BM. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail. 2001 Sep; 7(3):221-8.
        View in: PubMed
      136. Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. 2001 Apr 15; 110(6):425-33.
        View in: PubMed
      137. Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, Rydén L. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med. 2001 Jan 22; 161(2):165-71.
        View in: PubMed
      138. Rydén L, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J. 2000 Dec; 21(23):1967-78.
        View in: PubMed
      139. Sculpher MJ, Poole L, Cleland J, Drummond M, Armstrong PW, Horowitz JD, Massie BM, Poole-Wilson PA, Ryden L. Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group. Eur J Heart Fail. 2000 Dec; 2(4):447-54.
        View in: PubMed
      140. Massie BM, Teerlink JR. Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined. Am J Med. 2000 Oct 1; 109(5):431-3.
        View in: PubMed
      141. Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med. 2000 Sep 25; 160(17):2645-50.
        View in: PubMed
      142. Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, Massie B, Mosser DD, Sherman MY. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol. 2000 Sep; 20(18):6826-36.
        View in: PubMed
      143. Franciosa JA, Abraham WT, Fowler M, Gilbert EM, Greenberg B, Massie BM, Chen T, Lukas MA, Nelson JJ. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. J Card Fail. 2000 Sep; 6(3):264-71.
        View in: PubMed
      144. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000 Aug 8; 102(6):611-6.
        View in: PubMed
      145. Ashton CM, Bozkurt B, Colucci WB, Kiefe CI, Mann DL, Massie BM, Slawsky MT, Tierney WM, West JA, Whellan DJ, Wray NP. Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. Med Care. 2000 Jun; 38(6 Suppl 1):I26-37.
        View in: PubMed
      146. Teerlink JR, Massie BM. The role of beta-blockers in preventing sudden death in heart failure. J Card Fail. 2000 Jun; 6(2 Suppl 1):25-33.
        View in: PubMed
      147. Cho WK, Ebihara S, Nalbantoglu J, Gilbert R, Massie B, Holland P, Karpati G, Petrof BJ. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther. 2000 Mar 20; 11(5):701-14.
        View in: PubMed
      148. Go AS, Rao RK, Dauterman KW, Massie BM. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000 Feb 15; 108(3):216-26.
        View in: PubMed
      149. Cuffe MS, Califf RM, Adams KF, Bourge RC, Colucci W, Massie B, O'Connor CM, Pina I, Quigg R, Silver M, Robinson LA, Leimberger JD, Gheorghiade M. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J. 2000 Jan; 139(1 Pt 1):15-22.
        View in: PubMed
      150. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, Packer M, Massie BM. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation. 2000 Jan 4-11; 101(1):40-6.
        View in: PubMed
      151. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Rydén L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999 Dec 7; 100(23):2312-8.
        View in: PubMed
      152. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV, Massie BM, Cooper W. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999 Dec 13-27; 159(22):2673-7.
        View in: PubMed
      153. O'Connor CM, Gattis WA, Gheorghiade M, Granger CB, Gilbert J, McKenney JM, Messineo FC, Burnett JC, Katz SD, Elkayam U, Kasper EK, Goldstein S, Cody RJ, Massie BM. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J. 1999 Dec; 138(6 Pt 1):1140-8.
        View in: PubMed
      154. Teerlink JR, Massie BM. Beta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol. 1999 Nov 4; 84(9A):94R-102R.
        View in: PubMed
      155. Baker DW, Hayes RP, Massie BM, Craig CA. Variations in family physicians' and cardiologists' care for patients with heart failure. Am Heart J. 1999 Nov; 138(5 Pt 1):826-34.
        View in: PubMed
      156. Heidenreich PA, Ruggerio CM, Massie BM. Effect of a home monitoring system on hospitalization and resource use for patients with heart failure. Am Heart J. 1999 Oct; 138(4 Pt 1):633-40.
        View in: PubMed
      157. Teerlink JR, Massie BM. The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. Am Heart J. 1999 Aug; 138(2 Pt 1):193-7.
        View in: PubMed
      158. Frances CD, Go AS, Dauterman KW, Deosaransingh K, Jung DL, Gettner S, Newman JM, Massie BM, Browner WS. Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? Arch Intern Med. 1999 Jul 12; 159(13):1429-36.
        View in: PubMed
      159. Bello D, Shah NB, Edep ME, Tateo IM, Massie BM. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure. Am Heart J. 1999 Jul; 138(1 Pt 1):100-7.
        View in: PubMed
      160. Alexander M, Grumbach K, Remy L, Rowell R, Massie BM. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J. 1999 May; 137(5):919-27.
        View in: PubMed
      161. Cleland JG, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L. Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study. Eur J Heart Fail. 1999 Mar; 1(1):73-9.
        View in: PubMed
      162. Cleland JG, Massie BM, Packer M. Sudden death in heart failure: vascular or electrical? Eur J Heart Fail. 1999 Mar; 1(1):41-5.
        View in: PubMed
      163. Simonini A, Chang K, Yue P, Long CS, Massie BM. Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. Heart. 1999 Mar; 81(3):303-7.
        View in: PubMed
      164. Mansoor GA, Massie BM. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure. Blood Press Monit. 1999; 4 Suppl 1:S19-22.
        View in: PubMed
      165. Massie BM. The safety of calcium-channel blockers. Clin Cardiol. 1998 Dec; 21(12 Suppl 2):II12-7.
        View in: PubMed
      166. Bello D, Massie BM. The current role of amiodarone in patients with congestive heart failure. Cleve Clin J Med. 1998 Oct; 65(9):479-89.
        View in: PubMed
      167. Massie BM. Clinical trials in heart failure: can we expect the results to be replicated in clinical practice? J Card Fail. 1998 Sep; 4(3):243-7.
        View in: PubMed
      168. Massie BM. 15 years of heart-failure trials: what have we learned? Lancet. 1998 Aug; 352 Suppl 1:SI29-33.
        View in: PubMed
      169. Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol. 1998 Aug; 30(8):1615-30.
        View in: PubMed
      170. Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 1998 Jul; 275(1 Pt 2):H250-8.
        View in: PubMed
      171. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J. 1998 Jun; 135(6 Pt 2 Su):S293-309.
        View in: PubMed
      172. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J. 1998 Jun; 135(6 Pt 2 Su):S310-9.
        View in: PubMed
      173. Massie BM. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris. Am J Hypertens. 1998 Apr; 11(4 Pt 3):95S-102S.
        View in: PubMed
      174. Howell JM, Lochmüller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther. 1998 Mar 20; 9(5):629-34.
        View in: PubMed
      175. Massie BM, Cleland JG, Armstrong PW, Horowitz JD, Packer M, Poole-Wilson PA, Ryden L, Lars R. Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators. J Card Fail. 1998 Mar; 4(1):3-8.
        View in: PubMed
      176. Shah NB, Der E, Ruggerio C, Heidenreich PA, Massie BM. Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J. 1998 Mar; 135(3):373-8.
        View in: PubMed
      177. Massie BM, Abdalla I. Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role? Prog Cardiovasc Dis. 1998 Jan-Feb; 40(4):357-69.
        View in: PubMed
      178. Massie BM. Mibefradil: a selective T-type calcium antagonist. Am J Cardiol. 1997 Nov 6; 80(9A):23I-32I.
        View in: PubMed
      179. Massie BM. News from the FDA Cardio-renal Advisory Committee meeting of June 26, 1997. Circulation. 1997 Oct 21; 96(8):2483.
        View in: PubMed
      180. Massie BM, Lacourcière Y, Viskoper R, Woittiez A, Kobrin I. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists. Am J Cardiol. 1997 Aug 21; 80(4B):27C-33C.
        View in: PubMed
      181. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997 Aug; 30(2):518-26.
        View in: PubMed
      182. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997 Jul; 30(1):27-34.
        View in: PubMed
      183. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997 Jun; 133(6):703-12.
        View in: PubMed
      184. Massie BM, Chrysant SG, Jain A, Weir M, Weiss R, Korrin I. Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD. Clin Cardiol. 1997 Jun; 20(6):562-8.
        View in: PubMed
      185. Massie BM. Heart failure 1997: a time to take stock. Curr Opin Cardiol. 1997 May; 12(3):209-17.
        View in: PubMed
      186. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation. 1997 Apr 15; 95(8):2007-14.
        View in: PubMed
      187. Massie BM. Analyses of cost effectiveness in the management of essential hypertension: what they can and what they do not teach us. Clin Cardiol. 1996 Oct; 19(10):810-6.
        View in: PubMed
      188. Simonini A, Massie BM, Long CS, Qi M, Samarel AM. Alterations in skeletal muscle gene expression in the rat with chronic congestive heart failure. J Mol Cell Cardiol. 1996 Aug; 28(8):1683-91.
        View in: PubMed
      189. Massie BM, Shah NB, Pitt B, Packer M. Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan. Am Heart J. 1996 Jul; 132(1 Pt 1):130-6.
        View in: PubMed
      190. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res. 1996 Jul; 79(1):128-36.
        View in: PubMed
      191. Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation. 1996 Jun 15; 93(12):2128-34.
        View in: PubMed
      192. Massie BM, Shah NB. The heart failure epidemic: magnitude of the problem and potential mitigating approaches. Curr Opin Cardiol. 1996 May; 11(3):221-6.
        View in: PubMed
      193. Paquet L, Massie B, Mains RE. Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci. 1996 Feb 1; 16(3):964-73.
        View in: PubMed
      194. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol. 1996 Jan; 27(1):140-5.
        View in: PubMed
      195. Petrof BJ, Acsadi G, Jani A, Massie B, Bourdon J, Matusiewicz N, Yang L, Lochmüller H, Karpati G. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am J Respir Cell Mol Biol. 1995 Nov; 13(5):508-17.
        View in: PubMed
      196. Yamani MH, Wells L, Massie BM, Ammon S, Der E, Prouty K. Relation of the nine-minute self-powered treadmill test to maximal exercise capacity and skeletal muscle function in patients with congestive heart failure. Am J Cardiol. 1995 Oct 15; 76(11):788-92.
        View in: PubMed
      197. Materson BJ, Reda DJ, Preston RA, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, et al. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 1995 Sep 11; 155(16):1757-62.
        View in: PubMed
      198. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995 Jul 13; 333(2):77-82.
        View in: PubMed
      199. Yamani MH, Sahgal P, Wells L, Massie BM. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance. J Am Coll Cardiol. 1995 May; 25(6):1232-8.
        View in: PubMed
      200. Massie BM, Shah NB. Future approaches to pharmacologic therapy for congestive heart failure. Curr Opin Cardiol. 1995 May; 10(3):229-37.
        View in: PubMed
      201. Massie BM, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995 Mar 15; 91(6):1814-23.
        View in: PubMed
      202. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 1995 Mar; 2(2):107-15.
        View in: PubMed
      203. Schaefer S, Schwartz GG, Steinman S, Garcia J, Trocha SD, Weiner MW, Massie BM. Effects of regional myocardial lidocaine infusion on high energy phosphates. J Mol Cell Cardiol. 1994 Dec; 26(12):1601-11.
        View in: PubMed
      204. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994 Nov 16; 272(19):1528-34.
        View in: PubMed
      205. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol. 1994 Nov 15; 24(6):1492-8.
        View in: PubMed
      206. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH, Johnson JC, Oken C, Massie BM. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA. 1994 Nov 9; 272(18):1442-6.
        View in: PubMed
      207. Chou TM, Sweeney JP, Massie BM. Marked T-wave inversion after internal jugular cannulation complicated by neck hematoma. Am Heart J. 1994 Nov; 128(5):1038-40.
        View in: PubMed
      208. Yamani MH, Massie BM. Hypertension, myocardial ischemia, and sudden death. Curr Opin Cardiol. 1994 Sep; 9(5):542-50.
        View in: PubMed
      209. Massie BM. A personal perspective on the treatment of heart failure in 1994. Curr Opin Cardiol. 1994 May; 9(3):255-63.
        View in: PubMed
      210. Massie BM. First-line therapy for hypertension: different patients, different needs. Geriatrics. 1994 Apr; 49(4):22-30.
        View in: PubMed
      211. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW, Owens T. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res. 1994 Jan; 74(1):64-73.
        View in: PubMed
      212. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc. 1993 Dec; 68(12):1214-8.
        View in: PubMed
      213. Singh SN, Fletcher RD, Fisher S, Lazzeri D, Deedwania P, Lewis D, Massie B, Singh BN, Colling C. Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators. Am J Cardiol. 1993 Nov 26; 72(16):99F-102F.
        View in: PubMed
      214. Massie BM, Szlachcic Y, Tubau JF, O'Kelly BF, Ammon S, Chin W. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension: a case-control study. J Am Coll Cardiol. 1993 Nov 15; 22(6):1598-606.
        View in: PubMed
      215. Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM, et al. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). Circulation. 1993 Aug; 88(2):492-501.
        View in: PubMed
      216. Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. J Am Coll Cardiol. 1993 Jul; 22(1):65-72.
        View in: PubMed
      217. Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol. 1993 Jul; 75(1):373-81.
        View in: PubMed
      218. Massie BM, Mangano DT. Assessment of perioperative risk: have we put the cart before the horse. J Am Coll Cardiol. 1993 May; 21(6):1353-6.
        View in: PubMed
      219. Massie BM, Mangano DT. Risk stratification for noncardiac surgery. How (and why)? Circulation. 1993 May; 87(5):1752-5.
        View in: PubMed
      220. Figueredo VM, Brandes R, Weiner MW, Massie BM, Camacho SA. Endocardial versus epicardial differences of intracellular free calcium under normal and ischemic conditions in perfused rat hearts. Circ Res. 1993 May; 72(5):1082-90.
        View in: PubMed
      221. Massie BM, Rothenberg D. Publication of sponsored symposiums in medical journals. N Engl J Med. 1993 Apr 22; 328(16):1196-7; author reply 1197-8.
        View in: PubMed
      222. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993 Apr 1; 328(13):914-21.
        View in: PubMed
      223. Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology. 1993 Jan; 43(1):125-31.
        View in: PubMed
      224. Degroot M, Massie BM, Boska M, Gober J, Miller RG, Weiner MW. Dissociation of [H+] from fatigue in human muscle detected by high time resolution 31P-NMR. Muscle Nerve. 1993 Jan; 16(1):91-8.
        View in: PubMed
      225. Massie BM. Angiotensin-converting enzyme inhibitors as cardioprotective agents. Am J Cardiol. 1992 Dec 21; 70(21):10I-17I.
        View in: PubMed
      226. Massie BM. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J. 1992 Dec; 13 Suppl G:53-60.
        View in: PubMed
      227. Figueredo VM, Brandes R, Weiner MW, Massie BM, Camacho SA. Cardiac contractile dysfunction during mild coronary flow reductions is due to an altered calcium-pressure relationship in rat hearts. J Clin Invest. 1992 Nov; 90(5):1794-802.
        View in: PubMed
      228. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, et al. The heart in hypertension. N Engl J Med. 1992 Oct 1; 327(14):998-1008.
        View in: PubMed
      229. Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Control Clin Trials. 1992 Oct; 13(5):339-50.
        View in: PubMed
      230. Schwartz GG, Schaefer S, Trocha SD, Garcia J, Steinman S, Massie BM, Weiner MW. Effect of supranormal coronary blood flow on energy metabolism and systolic function of porcine left ventricle. Cardiovasc Res. 1992 Oct; 26(10):1001-6.
        View in: PubMed
      231. Minotti JR, Pillay P, Chang L, Wells L, Massie BM. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation. 1992 Sep; 86(3):903-8.
        View in: PubMed
      232. Brandes R, Figueredo VM, Camacho SA, Massie BM, Weiner MW. Suppression of motion artifacts in fluorescence spectroscopy of perfused hearts. Am J Physiol. 1992 Sep; 263(3 Pt 2):H972-80.
        View in: PubMed
      233. Nauman D, Greenberg B, Massie B, Bristow JD, Cheitlin M. Effects of stopping long-term vasodilator therapy in patients with chronic aortic insufficiency. Chest. 1992 Sep; 102(3):720-4.
        View in: PubMed
      234. O'Kelly B, Browner WS, Massie B, Tubau J, Ngo L, Mangano DT. Ventricular arrhythmias in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 1992 Jul 8; 268(2):217-21.
        View in: PubMed
      235. Chin WL, O'Kelly B, Tubau JF, Szlachcic J, Brown D, Wisneski JA, Ammon S, Massie BM. Diagnostic accuracy of exercise thallium-201 scintigraphy in men with asymptomatic essential hypertension. Am J Hypertens. 1992 Jul; 5(7):465-72.
        View in: PubMed
      236. Minotti JR, Massie BM. Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart? Circulation. 1992 Jun; 85(6):2323-5.
        View in: PubMed
      237. Schaefer S, Schwartz GG, Steinman SK, Meyerhoff DJ, Massie BM, Weiner MW. Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium. Magn Reson Med. 1992 Jun; 25(2):260-72.
        View in: PubMed
      238. Minotti JR, Christoph I, Massie BM. Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure. Chest. 1992 May; 101(5 Suppl):333S-339S.
        View in: PubMed
      239. Massie BM, Der E, Herman TS, Topolski P, Park GD, Stewart WH. 24-hour efficacy of once-daily diltiazem in essential hypertension. Clin Cardiol. 1992 May; 15(5):365-8.
        View in: PubMed
      240. Szlachcic J, Tubau JF, O'Kelly B, Ammon S, Daiss K, Massie BM. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension? J Am Coll Cardiol. 1992 Mar 15; 19(4):803-8.
        View in: PubMed
      241. Wilson RA, McDonald RW, Bristow JD, Cheitlin M, Nauman D, Massie B, Greenberg B. Correlates of aortic distensibility in chronic aortic regurgitation and relation to progression to surgery. J Am Coll Cardiol. 1992 Mar 15; 19(4):733-8.
        View in: PubMed
      242. Schwartz GG, Steinman S, Garcia J, Greyson C, Massie B, Weiner MW. Energetics of acute pressure overload of the porcine right ventricle. In vivo 31P nuclear magnetic resonance. J Clin Invest. 1992 Mar; 89(3):909-18.
        View in: PubMed
      243. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, Garcia J, Massie BM, Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation. 1992 Jan; 85(1):342-9.
        View in: PubMed
      244. Minotti JR, Christoph I, Oka R, Weiner MW, Wells L, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest. 1991 Dec; 88(6):2077-82.
        View in: PubMed
      245. Haeusslein EA, Greenberg BH, Massie BM. Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure? Chest. 1991 Nov; 100(5):1312-5.
        View in: PubMed
      246. Mangano DT, Massie BM, Browner WS. The dipyridamole-thallium test. Circulation. 1991 Oct; 84(4):1879-80.
        View in: PubMed
      247. Wilson R, Perlmutter N, Jacobson N, Siemienczuk D, Szlachcic J, Bristow JD, Cheitlin M, Massie B, Greenberg B. Effects of long-term vasodilator therapy on electrocardiographic abnormalities in chronic aortic regurgitation. Am J Cardiol. 1991 Oct 1; 68(9):935-9.
        View in: PubMed
      248. Schwartz GG, Schaefer S, Trocha SD, Steinman S, Gober J, Garcia J, Massie B, Weiner MW. Metabolic and functional consequences of blunted myocardial reactive hyperemia. Am J Physiol. 1991 Sep; 261(3 Pt 2):H892-900.
        View in: PubMed
      249. Mangano DT, London MJ, Tubau JF, Browner WS, Hollenberg M, Krupski W, Layug EL, Massie B. Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group. Circulation. 1991 Aug; 84(2):493-502.
        View in: PubMed
      250. Gober JR, Schwartz GG, Schaefer S, Massie BM, Matson GB, Weiner MW, Karczmar GS. 31P MRS of myocardial inorganic phosphate using radiofrequency gradient echoes. Magn Reson Med. 1991 Aug; 20(2):171-83.
        View in: PubMed
      251. Szlachcic J, Tubau JF, O'Kelly B, Ammon S, Massie BM. Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients. J Cardiovasc Pharmacol. 1991; 18 Suppl 1:S106-8.
        View in: PubMed
      252. Schwartz GG, Schaefer S, Gober J, Meyerhoff DJ, Smekal A, Massie B, Weiner MW. Myocardial high-energy phosphates in reactive hyperemia. Am J Physiol. 1990 Oct; 259(4 Pt 2):H1190-6.
        View in: PubMed
      253. Minotti JR, Johnson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, Cagle TG, Chick TW, Massie BM, Icenogle MV. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest. 1990 Sep; 86(3):751-8.
        View in: PubMed
      254. Massie BM. All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme inhibitor: a protagonist's viewpoint. Am J Cardiol. 1990 Aug 15; 66(4):439-43.
        View in: PubMed
      255. Schwartz GG, Schaefer S, Meyerhoff DJ, Gober J, Fochler P, Massie B, Weiner MW. Dynamic relation between myocardial contractility and energy metabolism during and following brief coronary occlusion in the pig. Circ Res. 1990 Aug; 67(2):490-500.
        View in: PubMed
      256. Szlachcic J, Tubau JF, O'Kelly B, Massie BM. Correlates of diastolic filling abnormalities in hypertension: a Doppler echocardiographic study. Am Heart J. 1990 Aug; 120(2):386-91.
        View in: PubMed
      257. Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massie B. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol. 1990 May 1; 65(16):1154-61.
        View in: PubMed
      258. Szlachcic J, Hall WD, Tubau JF, Porter V, Vollmer C, Wollam G, Hirsch A, Massie B. Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study. Cardiovasc Drugs Ther. 1990 Apr; 4(2):427-33.
        View in: PubMed
      259. Schaefer S, Schwartz GG, Gober JR, Wong AK, Camacho SA, Massie B, Weiner MW. Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest. 1990 Mar; 85(3):706-13.
        View in: PubMed
      260. Gober JR, Schaefer S, Camacho SA, DeGroot M, Obregon R, Botvinick EH, Weiner M, Massie B. Epicardial and endocardial localized 31P magnetic resonance spectroscopy: evidence for metabolic heterogeneity during regional ischemia. Magn Reson Med. 1990 Feb; 13(2):204-15.
        View in: PubMed
      261. Massie BM. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators? Cardiovasc Clin. 1990; 21(1):251-62; discussion 263-4.
        View in: PubMed
      262. Schaefer S, Schwartz GG, Gober JR, Massie B, Weiner MW. Magnetic resonance spectroscopy. Evaluation of ischemic heart disease. Invest Radiol. 1989 Dec; 24(12):969-72.
        View in: PubMed
      263. Weiner MW, Hetherington H, Hubesch B, Karczmar G, Massie B, Maudsley A, Meyerhoff DJ, Sappey-Marinier D, Schaefer S, Twieg DB, et al. Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed. 1989 Dec; 2(5-6):290-7.
        View in: PubMed
      264. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989 Sep; 14(3):564-70; discussion 571-2.
        View in: PubMed
      265. Schaefer S, Massie B, Weiner MW. Magnetic resonance spectroscopy of the heart. Cardiol Clin. 1989 Aug; 7(3):697-712.
        View in: PubMed
      266. Tubau JF, Szlachcic J, Braun S, Massie BM. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension. 1989 Jul; 14(1):1-8.
        View in: PubMed
      267. Tubau JF, Szlachcic J, Hollenberg M, Massie BM. Usefulness of thallium-201 scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy. Am J Cardiol. 1989 Jul 1; 64(1):45-9.
        View in: PubMed
      268. O'Kelly BF, Massie BM, Tubau JF, Szlachcic J. Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension. Ann Intern Med. 1989 Jun 15; 110(12):1017-26.
        View in: PubMed
      269. Schaefer S, Camacho SA, Gober J, Obregon RG, DeGroot MA, Botvinick EH, Massie B, Weiner MW. Response of myocardial metabolites to graded regional ischemia: 31P NMR spectroscopy of porcine myocardium in vivo. Circ Res. 1989 May; 64(5):968-76.
        View in: PubMed
      270. Bouchard A, Yock P, Schiller NB, Blumlein S, Botvinick EH, Greenberg B, Cheitlin M, Massie BM. Value of color Doppler estimation of regurgitant volume in patients with chronic aortic insufficiency. Am Heart J. 1989 May; 117(5):1099-105.
        View in: PubMed
      271. Siemienczuk D, Greenberg B, Morris C, Massie B, Wilson RA, Topic N, Bristow JD, Cheitlin M. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. Ann Intern Med. 1989 Apr 15; 110(8):587-92.
        View in: PubMed
      272. Szlachcic J, Tubau JF, Vollmer C, Massie BM. Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension. Am J Cardiol. 1989 Jan 15; 63(3):198-201.
        View in: PubMed
      273. Massie BM, Tubau JF, Szlachcic J, O'Kelly BF. Hypertensive heart disease: the critical role of left ventricular hypertrophy. J Cardiovasc Pharmacol. 1989; 13 Suppl 1:S18-24.
        View in: PubMed
      274. Schaefer S, Gober J, Valenza M, Karczmar GS, Matson GB, Camacho SA, Botvinick EH, Massie B, Weiner MW. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol. 1988 Dec; 12(6):1449-55.
        View in: PubMed
      275. Vandenbossche JL, Massie BM, Schiller NB, Karliner JS. Relation of left ventricular shape to volume and mass in patients with minimally symptomatic chronic aortic regurgitation. Am Heart J. 1988 Oct; 116(4):1022-7.
        View in: PubMed
      276. Massie BM. Angiotensin-converting enzyme inhibition in mild to moderate congestive heart failure: an evolving approach. Am J Hypertens. 1988 Oct; 1(4 Pt 2):402S-409S.
        View in: PubMed
      277. Wilson RA, Greenberg BH, Massie BM, Bristow JD, Cheitlin M, Siemienczuk D, Krishnamurthy GT, Thomas D. Left ventricular response to submaximal and maximal exercise in asymptomatic aortic regurgitation. Am J Cardiol. 1988 Sep 15; 62(9):606-10.
        View in: PubMed
      278. Rajagopalan B, Conway MA, Massie B, Radda GK. Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure. Am J Cardiol. 1988 Sep 9; 62(8):53E-57E.
        View in: PubMed
      279. Papadakis MA, Massie BM. Appropriateness of digoxin use in medical outpatients. Am J Med. 1988 Sep; 85(3):365-8.
        View in: PubMed
      280. Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation. 1988 Aug; 78(2):320-6.
        View in: PubMed
      281. Massie BM. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? I. Introduction. J Am Coll Cardiol. 1988 Aug; 12(2):547-50.
        View in: PubMed
      282. Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D, Topic N, Wilson RA, Szlachcic J, Thomas D. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation. 1988 Jul; 78(1):92-103.
        View in: PubMed
      283. Giles TD, Massie BM. Role of calcium antagonists as initial pharmacologic monotherapy for systemic hypertension in patients over 60 years of age. Am J Cardiol. 1988 Jun 15; 61(16):13H-17H.
        View in: PubMed
      284. Massie BM. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure. Am J Med. 1988 Apr 15; 84(4A):36-46.
        View in: PubMed
      285. Massie BM. Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment. Am J Med. 1988 Mar 11; 84(3A):75-82.
        View in: PubMed
      286. Massie BM. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol. J Cardiovasc Pharmacol. 1988; 12 Suppl 4:S55-8.
        View in: PubMed
      287. Massie BM. Demographic considerations in the selection of antihypertensive therapy. Am J Cardiol. 1987 Dec 14; 60(17):121I-126I.
        View in: PubMed
      288. Tubau JF, Szlachcic J, London MJ, Hollenberg M, Mangano D, Massie BM. Systemic hypertension, left ventricular hypertrophy and coronary artery disease. Am J Cardiol. 1987 Dec 14; 60(17):23I-28I.
        View in: PubMed
      289. Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation. 1987 Nov; 76(5):1009-19.
        View in: PubMed
      290. Tubau JF, Wikman-Coffelt J, Massie BM, Sievers R, Parmley WW. Improved myocardial efficiency in the working perfused heart of the spontaneously hypertensive rat. Hypertension. 1987 Oct; 10(4):396-403.
        View in: PubMed
      291. Massie BM, Cornyn J, Topic N, Loge D, Podolin RA. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside. Am J Cardiol. 1987 Sep 15; 60(8):647-53.
        View in: PubMed
      292. Massie BM, Conway M, Yonge R, Frostick S, Sleight P, Ledingham J, Radda G, Rajagopalan B. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol. 1987 Aug 1; 60(4):309-15.
        View in: PubMed
      293. Tubau JF, Wikman-Coffelt J, Massie BM, Szlachcic J, Parmley WW, Sievers R, Henderson S. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat. Cardiovasc Res. 1987 Aug; 21(8):606-14.
        View in: PubMed
      294. Massie B, MacCarthy EP, Ramanathan KB, Weiss RJ, Anderson M, Eidelson BA, Labreche DG, Tubau JF, Ulep D, Bartels D. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. Ann Intern Med. 1987 Aug; 107(2):150-7.
        View in: PubMed
      295. Cornyn JW, Massie BM, Greenberg B, Loge DL, Thomas D, Bristow JD, Cheitlin M, Krishnamurthy G. Reproducibility of rest and exercise left ventricular ejection fraction and volumes in chronic aortic regurgitation. Am J Cardiol. 1987 Jun 1; 59(15):1361-5.
        View in: PubMed
      296. Massie BM, Tubau JF, Szlachcic J. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications. Circulation. 1987 Jun; 75(6 Pt 2):V163-9.
        View in: PubMed
      297. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation. 1987 May; 75(5 Pt 2):IV11-9.
        View in: PubMed
      298. Szlachcic J, Hirsch AT, Tubau JF, Vollmer C, Henderson S, Massie BM. Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity. Am J Cardiol. 1987 Feb 15; 59(5):393-9.
        View in: PubMed
      299. Massie BM, Tubau JF, Szlachcic J, Vollmer C. Comparison and additivity of nitrendipine and hydrochlorothiazide in systemic hypertension. Am J Cardiol. 1986 Sep 30; 58(8):16D-19D.
        View in: PubMed
      300. Szlachcic J, Massie BM, Greenberg B, Thomas D, Cheitlin M, Bristow JD. Intertest variability of echocardiographic and chest X-ray measurements: implications for decision making in patients with aortic regurgitation. J Am Coll Cardiol. 1986 Jun; 7(6):1310-7.
        View in: PubMed
      301. Massie B. Updated diagnosis and management of congestive heart failure. Geriatrics. 1986 Mar; 41(3):30-5, 38-42.
        View in: PubMed
      302. Pool PE, Massie BM, Venkataraman K, Hirsch AT, Samant DR, Seagren SC, Gaw J, Salel AF, Tubau JF. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Am J Cardiol. 1986 Feb 1; 57(4):212-7.
        View in: PubMed
      303. Cornyn JW, Massie BM, Unverferth DV, Leier CV. Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol. 1986 Feb 1; 57(4):238-41.
        View in: PubMed
      304. Massie BM. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers. Am J Cardiol. 1985 Dec 6; 56(16):97H-100H.
        View in: PubMed
      305. Inouye IK, Massie BM, Loge D, Tubau JF. Assessment of left ventricular diastolic filling: comparison of fixed and varying region of interest approaches. Am Heart J. 1985 Oct; 110(4):840-4.
        View in: PubMed
      306. Inouye IK, Hirsch AT, Loge D, Tubau JF, Massie BM. Left ventricular filling is usually normal in uncomplicated coronary disease. Am Heart J. 1985 Aug; 110(2):326-31.
        View in: PubMed
      307. Creager MA, Massie BM, Faxon DP, Friedman SD, Kramer BL, Weiner DA, Ryan TJ, Topic N, Melidossian CD. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol. 1985 Jul; 6(1):163-73.
        View in: PubMed
      308. Hollenberg M, Go M, Massie BM, Wisneski JA, Gertz EW. Influence of R-wave amplitude on exercise-induced ST depression: need for a "gain factor" correction when interpreting stress electrocardiograms. Am J Cardiol. 1985 Jul 1; 56(1):13-7.
        View in: PubMed
      309. Massie B, Bourassa M, DiBianco R, Hess M, Konstam M, Likoff M, Packer M. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation. 1985 May; 71(5):963-71.
        View in: PubMed
      310. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1; 55(8):1037-42.
        View in: PubMed
      311. Massie BM, Kramer BL, Loge D, Topic N, Greenberg BH, Cheitlin MD, Bristow JD, Byrd RC. Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: relation to simultaneous hemodynamic measurements. J Am Coll Cardiol. 1985 Apr; 5(4):847-55.
        View in: PubMed
      312. Greenberg B, Massie B, Thomas D, Bristow JD, Cheitlin M, Broudy D, Szlachcic J, Krishnamurthy G. Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency. Circulation. 1985 Mar; 71(3):458-65.
        View in: PubMed
      313. Vandenbossche JL, Kramer BL, Massie BM, Morris DL, Karliner JS. Two-dimensional echocardiographic evaluation of the size, function and shape of the left ventricle in chronic aortic regurgitation: comparison with radionuclide angiography. J Am Coll Cardiol. 1984 Dec; 4(6):1195-206.
        View in: PubMed
      314. Massie BM, Hirsch AT, Inouye IK, Tubau JF. Calcium channel blockers as antihypertensive agents. Am J Med. 1984 Oct 5; 77(4A):135-42.
        View in: PubMed
      315. Massie BM, Kramer BL, Topic N. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses. Circulation. 1984 Jun; 69(6):1135-41.
        View in: PubMed
      316. Inouye IK, Massie BM, Loge D, Simpson P, Tubau JF. Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities. Am J Cardiol. 1984 Jun 1; 53(11):1583-7.
        View in: PubMed
      317. Inouye IK, Massie BM, Benowitz N, Simpson P, Loge D. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide. Am J Cardiol. 1984 Jun 1; 53(11):1588-92.
        View in: PubMed
      318. Massie BM, Wisneski JA, Hollenberg M, Gertz EW, Henderson S. Quantitative analysis of seven-pinhole tomographic thallium-201 scintigrams: improved sensitivity and estimation of the extent of coronary involvement by evaluation of radiotracer uptake and clearance. J Am Coll Cardiol. 1984 May; 3(5):1178-86.
        View in: PubMed
      319. Massie BM, Kramer BL, Topic N. Long-term captopril therapy for chronic congestive heart failure. Am J Cardiol. 1984 May 1; 53(9):1316-20.
        View in: PubMed
      320. Massie BM, Wisneski JA, Inouye IK, Hollenberg M, Gertz EW, Henderson S. Detection and quantification of previous myocardial infarction by exercise-redistribution tomographic thallium-201 scintigraphy. Am J Cardiol. 1984 May 1; 53(9):1244-9.
        View in: PubMed
      321. Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 1984 Apr; 3(4):902-8.
        View in: PubMed
      322. Inouye I, Massie B, Benowitz N, Simpson P, Loge D, Topic N. Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin. Am J Cardiol. 1984 Jan 27; 53(3):24A-28A.
        View in: PubMed
      323. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984 Jan 1; 53(1):120-6.
        View in: PubMed
      324. Massie BM, Hollenberg M, Wisneski JA, Go M, Gertz EW, Henderson S. Scintigraphic quantification of myocardial ischemia: a new approach. Circulation. 1983 Oct; 68(4):747-55.
        View in: PubMed
      325. Massie BM. Myocardial hypertrophy and cardiac failure: a complex interrelationship. Am J Med. 1983 Sep 26; 75(3A):67-74.
        View in: PubMed
      326. Massie BM, Packer M, Hanlon JT, Combs DT. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure. J Am Coll Cardiol. 1983 Aug; 2(2):338-44.
        View in: PubMed
      327. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983 Apr; 67(4):807-16.
        View in: PubMed
      328. Massie BM, Kramer BL, Topic N. Converting-enzyme inhibitor therapy for chronic heart failure. Herz. 1983 Apr; 8(2):71-80.
        View in: PubMed
      329. Massie BM, Kramer BL, Topic N. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1197-203.
        View in: PubMed
      330. Topic N, Kramer B, Massie B. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1172-9.
        View in: PubMed
      331. Awan NA, Massie BM. Therapy of severe chronic congestive heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1125-6.
        View in: PubMed
      332. Kramer B, Massie B, Topic N. Hemodynamic differences between supine and upright exercise in patients with congestive heart failure. Circulation. 1982 Oct; 66(4):820-5.
        View in: PubMed
      333. Massie BM, Stern R, Hanlon JT, Haughom F. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure. Am Heart J. 1982 Sep; 104(3):581-6.
        View in: PubMed
      334. Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med. 1982 Jun 3; 306(22):1326-31.
        View in: PubMed
      335. Massie B, Kramer BL, Topic N, Henderson SG. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Circulation. 1982 Jun; 65(7):1374-81.
        View in: PubMed
      336. Massie BM, Wisneski J, Kramer B, Hollenberg M, Gertz E, Stern D. Comparison of myocardial thallium-201 clearance after maximal and submaximal exercise: implications for diagnosis of coronary disease: concise communication. J Nucl Med. 1982 May; 23(5):381-5.
        View in: PubMed
      337. Massie BM, Kramer BL, Gertz EW, Henderson SG. Radionuclide measurement of left ventricular volume: comparison of geometric and counts-based methods. Circulation. 1982 Apr; 65(4):725-30.
        View in: PubMed
      338. Kramer B, Topic N, Massie B. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Br J Clin Pharmacol. 1982; 14 Suppl 2:143S-151S.
        View in: PubMed
      339. Massie BM, Chan S. Antihypertensive therapy with prazosin in patients with left ventricular dysfunction. Improvement in cardiac performance and exercise tolerance. Chest. 1981 Dec; 80(6):692-7.
        View in: PubMed
      340. Massie BM, Kramer B, Haughom F. Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance. Circulation. 1981 Dec; 64(6):1218-26.
        View in: PubMed
      341. Massie BM, Bharati S, Scheinman MM, Lev M, Desai J, Rubeson E, Schmidt W. Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation. Circulation. 1981 Oct; 64(4):845-52.
        View in: PubMed
      342. Massie B, Botvinick E, Arnold S, Shames D, Brundage B, Hanlon JT, Sheldon K. Contrast enhancement of thallium-201 myocardial scintigrams: improved sensitivity with diminished specificity in coronary disease detection. Am Heart J. 1981 Jul; 102(1):37-44.
        View in: PubMed
      343. Massie BM, Kramer B, Shen E, Haughom F. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Br Heart J. 1981 Apr; 45(4):376-84.
        View in: PubMed
      344. Desai JM, Scheinman MM, Strauss HC, Massie B, O'Young J. Electrophysiologic effects on combined autonomic blockade in patients with sinus node disease. Circulation. 1981 Apr; 63(4):953-60.
        View in: PubMed
      345. Massie B, Kramer B, Haughom F. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. Circulation. 1981 Mar; 63(3):658-64.
        View in: PubMed
      346. Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O'Young J, Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981 Feb; 63(2):269-78.
        View in: PubMed
      347. Hanlon JT, Massie B, Riches W, Wilson J, Ellis RJ, Gertz EW. Rapidly progressive coronary artery bypass graft atherosclerosis. Report of a case documented by serial coronary arteriograms and pathologic examination. Chest. 1981 Jan; 79(1):96-9.
        View in: PubMed
      348. Chatterjee K, Rouleau JL, Massie BM. Hydralazine in chronic CHF. Acta Med Scand Suppl. 1981; 652:99-113.
        View in: PubMed
      349. Greenberg BH, Massie BM. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis. Circulation. 1980 Jun; 61(6):1212-6.
        View in: PubMed
      350. Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Ann Intern Med. 1980 May; 92(5):600-4.
        View in: PubMed
      351. Botvinick EH, Dunn RF, Hattner RS, Massie BM. A consideration of factors affecting the diagnostic accuracy of thallium-201 myocarial perfusion scintigraphy in detecting coronary artery disease. Semin Nucl Med. 1980 Apr; 10(2):157-67.
        View in: PubMed
      352. Massie BM, Botvinick EH, Brundage BH. Correlation of thallium-201 scintigrams with coronary anatomy: factors affecting region by region sensitivity. Am J Cardiol. 1979 Oct; 44(4):616-22.
        View in: PubMed
      353. Dash H, Massie BM, Botvinick EH, Brundage BH. The noninvasive identification of left main and three-vessel coronary artery disease by myocardial stress perfusion scintigraphy and treadmill exercise electrocardiography. Circulation. 1979 Aug; 60(2):276-84.
        View in: PubMed
      354. Bharati S, Bauernfiend R, Scheinman M, Massie B, Cheitlin M, Denes P, Wu D, Lev M, Rosen KM. Congenital abnormalities of the conduction system in two patients with tachyarrhythmias. Circulation. 1979 Mar; 59(3):593-606.
        View in: PubMed
      355. Massie BM, Botvinick EH, Werner JA, Chatterjee K, Parmley WW. Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction. Am J Cardiol. 1979 Feb; 43(2):186-92.
        View in: PubMed
      356. Massie BM, Chatterjee K. Vasodilator therapy of pump failure complicating acute myocardial infarction. Med Clin North Am. 1979 Jan; 63(1):25-51.
        View in: PubMed
      357. Massie B. Assessing the severity of aortic stenosis. Ann Intern Med. 1979 Jan; 90(1):123-4.
        View in: PubMed
      358. Massie BM, Botvinick EH, Brundage BH, Greenberg B, Shames D, Gelberg H. Relationship of regional myocardial perfusion to segmental wall motion: a physiologic basis for understanding the presence and reversibility of asynergy. Circulation. 1978 Dec; 58(6):1154-63.
        View in: PubMed
      359. Schor RA, Massie BM, Botvinick EH, Shames DM. Gallium-67 uptake in silent myocardial infarction: a case report. Radiology. 1978 Oct; 129(1):117-8.
        View in: PubMed
      360. Massie B, Kleid JJ, Schiller N. Echocardiography in ischemic heart disease: present status and future prospectives. Am Heart J. 1978 Oct; 96(4):543-9.
        View in: PubMed
      361. Massie B, Scheinman MM, Peters R, Desai J, Hirschfeld D, O'Young J. Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Circulation. 1978 Aug; 58(2):305-14.
        View in: PubMed
      362. Greenberg BH, Massie BM, Brundage BH, Botvinick EH, Parmley WW, Chatterjee K. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation. 1978 Aug; 58(2):273-9.
        View in: PubMed
      363. Chatterjee K, Massie B, Rubin S, Gelberg H, Brundage BH, Ports TA. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Am J Med. 1978 Jul; 65(1):134-45.
        View in: PubMed
      364. Scheinman MM, Strauss HC, Evans GT, Ryan C, Massie B, Wallace A. Adverse effects of sympatholytic agents in patients with hypertension and sinus node dysfunction. Am J Med. 1978 Jun; 64(6):1013-20.
        View in: PubMed
      365. Sharpe DN, Botvinick EH, Shames DM, Schiller NB, Massie BM, Chatterjee K, Parmley WW. The noninvasive diagnosis of right ventricular infarction. Circulation. 1978 Mar; 57(3):483-90.
        View in: PubMed
      366. Massie B, Botvinick EH, Shames D, Taradash M, Werner J, Schiller N. Myocardial perfusion scintigraphy in patients with mitral valve prolapse: Its advantage over stress electrocardiography in diagnosing associated coronary artery disease and its implications for the etiology of chest pain. Circulation. 1978 Jan; 57(1):19-26.
        View in: PubMed
      367. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol. 1977 Nov; 40(5):794-801.
        View in: PubMed
      368. Massie BM, Schiller NB, Ratshin RA, Parmley WW. Mitral-septal separation: new echocardiographic index of left ventricular function. Am J Cardiol. 1977 Jun; 39(7):1008-16.
        View in: PubMed
      369. Tyberg JV, Massie BM, Botvinick EH, Parmley W. The hemodynamics of coronary arterial stenosis. Cardiovasc Clin. 1977; 8(2):71-84.
        View in: PubMed
      370. Chatterjee K, Parmley WW, Massie B, Greenberg B, Werner J, Klausner S, Norman A. Oral hydralazine therapy for chronic refractory heart failure. Circulation. 1976 Dec; 54(6):879-83.
        View in: PubMed
      Barry's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (734) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (31) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP